Use of altered informed consent in pragmatic clinical research.

Published

Journal Article

There are situations in which the requirement to obtain conventional written informed consent can impose significant or even insurmountable barriers to conducting pragmatic clinical research, including some comparative effectiveness studies and cluster-randomized trials. Although certain federal regulations governing research in the United States (45 CFR 46) define circumstances in which any of the required elements may be waived, the same standards apply regardless of whether any single element is to be waived or whether consent is to be waived in its entirety. Using the same threshold for a partial or complete waiver limits the options available to institutional review boards as they seek to optimize a consent process. In this article, we argue that new standards are necessary in order to enable important pragmatic clinical research while at the same time protecting patients' rights and interests.

Full Text

Duke Authors

Cited Authors

  • McKinney, RE; Beskow, LM; Ford, DE; Lantos, JD; McCall, J; Patrick-Lake, B; Pletcher, MJ; Rath, B; Schmidt, H; Weinfurt, K

Published Date

  • October 2015

Published In

Volume / Issue

  • 12 / 5

Start / End Page

  • 494 - 502

PubMed ID

  • 26374677

Pubmed Central ID

  • 26374677

Electronic International Standard Serial Number (EISSN)

  • 1740-7753

International Standard Serial Number (ISSN)

  • 1740-7745

Digital Object Identifier (DOI)

  • 10.1177/1740774515597688

Language

  • eng